Navigation Links
Fuisz Pharma LLC Develops a New Generation of Oral Solid Dosage Form Shapes That Facilitate Swallowing and Esophageal Transit
Date:4/6/2011

MIAMI, April 6, 2011 /PRNewswire/ -- Fuisz Pharma LLC announced today a new generation of solid dosage form designs that facilitate swallowing and esophageal transit.

Clinical studies demonstrate that these new designs and principles thereof speed esophageal transit by 80%, ease the swallowing experience, and reduce the incidence of esophageal transit failure, as compared with the conventional tablet designs currently used.

Joseph Fuisz, managing partner of Fuisz Pharma stated: "We stand at a crossroads where there is a keen understanding of the importance of compliance and the challenges to compliance posed by an aging population throughout the developed world.  At the same time however, cost containment pressures -- manifested primarily in reimbursement schemes -- make it challenging for branded pharma to broadly adopt value added drug delivery technologies."

"Our intention with this effort was to take existing tablet granulations and approach the question of form – as it relates to swallowability – from first principles.  The results were quite astonishing in that we demonstrated the ability to make enormous improvements in the swallowability of conventionally manufactured dosage forms.  Literally, we are able to take the existing granulation and stamp out a dramatically better performing product.  This advance also applies to capsules.  We are pursuing new dosage form classification for these next generation shapes in order to properly recognize their therapeutic value and to maximize the life cycle management benefit to our partners."

Richard C. Fuisz, M.D., a founder of Fuisz Pharma, commented: "I have had the privilege of making substantial contributions to the development and commercialization of orally dissolving tablets and orally soluble films, both of which were granted new dosage form classification to distinguish them from the then existing dosage forms.  Our new solid dosage for
'/>"/>

SOURCE Fuisz Pharma LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Fuisz Pharma Releases Clinical Photos of Its Opioid Abuse Detection System
2. Fuisz Announces Issuance of Patent for the New Generation of Glucose and Other Analyte Analyzers
3. Fuisz Pharma Announces Acquisition of Key Anti Opiate Abuse Patent to Complement its Anti Opiate Abuse Platform
4. FUISZ Announces Advances in Devices and Solid Dosage Form
5. Fuisz Pharma Announces Novel Anti Abuse System for Opiates
6. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
7. Harnessing Patients Good Intentions Can Cut 33% of Americas Pharmacy-Related Waste
8. Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
9. Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
10. ACLJ Gets Win for Pro-Life Pharmacy Owners in Illinois After Lengthy Legal Battle
11. Vista Partners Updates Coverage on Pro-Pharmaceuticals, Inc.; Raises Target Price to $3.22
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... March 26, 2015 Huntington Memorial Hospital is ... perform transcatheter aortic valve replacement (TAVR), a minimally invasive ... revolutionary new way to replace an aortic valve without ... lung machine. The procedure is performed by ... Azhil ( Alex) Durairaj , MD, interventional cardiologist and ...
(Date:3/26/2015)... 2015 Cardiologists at Beaumont Hospital, ... commercial implant of a device recently approved by the ... fibrillation. The Watchman Left Atrial Appendage Closure implant is ... to reduce the risk of stroke. Atrial ... more than 5 million Americans. Twenty percent of all ...
(Date:3/26/2015)... , March 26, 2015 Over-the-counter ... average American consumer. However, a new survey of ... ailments from the common cold to diabetes, can ... The research, conducted by the Private Label Manufacturers ... over-the-counter healthcare products, including those essential for treatment ...
Breaking Medicine Technology:Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3Consumers can keep over-the-counter medicine affordable by using store brands 2
... aureus and, Methicillin-Resistant Staphylococcus aureus from Positive ... BD Diagnostics, a segment,of BD (Becton, Dickinson and ... it,received clearance from the U.S. Food and Drug ... new assay is the first test available to,rapidly ...
... Dec. 27 Allos,Therapeutics, Inc. (Nasdaq: ALTH ... (DMC) has completed the pre-specified 65-patient,safety review of ... trial of,PDX (pralatrexate) in patients with relapsed or ... the trial continue per the,protocol. This interim assessment ...
Cached Medicine Technology:BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures 2BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures 3Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 2Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 3Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 4Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 5
(Date:3/27/2015)... “ VXi BlueParott Reveal ” was ... Report, which features the latest and coolest technology products ... special reporter for NewsWatch, conducted the review and shared ... eliminating 90% of ambient noise. , Today, business is ... are important to any professional, voice calls are just ...
(Date:3/27/2015)... The Florida Center for Brain Tumor ... (ABC2), awarded $350,000 to support brain cancer research at ... Research Institute and H. Lee Moffitt Cancer Center and ... clear development path and potential to provide meaningful improvements ... , The awards fund research in areas on ...
(Date:3/27/2015)... 2015 The Thomas Scattergood ... grant-making foundation committed to raising its voice to ... delivered. , The Scattergood Foundation and The Kennedy ... Policy and Practice through the Annual Scattergood Foundation ... App is designed to guide the IBS sufferer ...
(Date:3/26/2015)... Elfster.com, the top-rated Secret Santa generator, ... list generator capabilities to its leading Secret Santa list ... list that one creates of things to do before ... the same name. Nowadays many millennials are creating ... summer achievements. , "We are greatly expanding our technology ...
(Date:3/26/2015)... 26, 2015 Dr. Rod J. ... Dallas Rhinoplasty Symposium and has trained over 6500 ... importance of evidence based medicine (EBM), that is, the ... conducted research. , "We often hear from rhinoplasty ... while we are certainly not trying to stifle these ...
Breaking Medicine News(10 mins):Health News:A Device to Tune out Background Noise was Recently Featured on NewsWatch Television 2Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 2Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 3Health News:SoundsLikeIBS Nominated For 3rd Annual Scattergood Innovation Award 2Health News:Plans for Bucket List Generator - Just In Time for Summer - Announced by Elfster 2Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2
... under constant stress, could severely damage major organs and ... have warned. ,Stress may lead to unhealthy ... too much alcohol and not getting enough exercise - ... ,For some people, being under constant stress can ...
... of tea daily can protect you from developing skin cancer, ... to strengthen the findings. ,Tea's disease-fighting properties appear ... cell carcinomas - most common forms of skin cancers usually ... that grow slowly over a period of months or even ...
... found in human blood inhibited 60 strains of HIV ... study published Thursday in the journal Cell//, the San ... HIV strains that have developed resistance to existing medications ... new HIV/AIDS drugs -- the Chronicle reports. ...
... when thirty poor women of the fishing community, living on ... The 1994 Transplant of Human Organ Act ... allowed to donate kidneys for transplantation. However a recent report ... indicate that several leading hospitals in the state encouraged the ...
... Approximately 50% of sexually active gay men in the UK had ... of the 2005 Gay Men’s Sex Survey//, Consuming Passions, which has ... 40% of gay men in the UK are unaware of their ... have not disclosed their HIV infection status. ,The ...
... 4,000 pregnant women one-fifth of them had to undergo emergency ... Researchers found that obesity impairs the ability of the uterus ... deliver the baby. ,In a study of 4,000 ... women had to undergo an emergency Caesarean Section birth because ...
Cached Medicine News:Health News:Modern Lifestyle Could Damage Heart 2Health News:Peptide Found in Human Blood Inhibits 60 Strains of HIV, Study Says 2Health News:Kidney Trade: Curbing the Sale 2Health News:Kidney Trade: Curbing the Sale 3Health News:One-fifth of Obese Women Undergo Caesarean Due to Uterus Failure 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: